Literature DB >> 12047383

Purification and characterization of VanXY(C), a D,D-dipeptidase/D,D-carboxypeptidase in vancomycin-resistant Enterococcus gallinarum BM4174.

Adrian H B Podmore1, Peter E Reynolds.   

Abstract

VanXY(C), a bifunctional enzyme from VanC-phenotype Enterococcus gallinarum BM4174 that catalyses D,D-peptidase and D,D-carboxypeptidase activities, was purified as the native protein, as a maltose-binding protein fusion and with an N-terminal tag containing six histidine residues. The kinetic parameters of His(6)-VanXY(C) were measured for a variety of precursors of peptidoglycan synthesis involved in resistance: for D-Ala-D-Ala, the K(m) was 3.6 mm and k(cat), 2.5 s(-1); for UDP-MurNAc-L-Ala-D-Glu-L-Lys-DAla-D-Ala (UDP-MurNAc-pentapeptide[Ala]), K(m) was 18.8 mm and k(cat) 6.2 s(-1); for D-Ala-D-Ser, K(m) was 15.5 mm and k(cat) 0.35 s(-1). His(6)-VanXYC was inactive against the peptidoglycan precursor UDP-MurNAc-L-Ala-D-Glu-L-Lys-D-Ala-D-Ser (UDP-MurNAc-pentapeptide[Ser]). The rate of hydrolysis of the terminal D-Ala of UDP-MurNAc-pentapeptide[Ala] was inhibited 30% by 2 mm D-Ala-D-Ser or UDP-MurNAc-pentapeptide[Ser]. Therefore preferential hydrolysis of substrates terminating in D-Ala would occur during peptidoglycan synthesis in E. gallinarum BM4174, leaving precursors ending in D-Ser with a lower affinity for glycopeptides to be incorporated into peptidoglycan. Mutation of an aspartate residue (Asp59) of His-tagged VanXY(C) corresponding to Asp68 in VanX to Ser or Ala, resulted in a 50% increase and 73% decrease, respectively, of the specificity constant (k(cat)/K(m)) for D-Ala-D-Ala. This situation is in contrast to VanX in which mutation of Asp68-->Ala produced a greater than 200,000-fold decrease in the substrate specificity constant. This suggests that Asp59, unlike Asp68 in VanX, does not have a pivotal role in catalysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12047383     DOI: 10.1046/j.1432-1033.2002.02946.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

Review 1.  Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine.

Authors:  Peter E Reynolds; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  Structural basis for the evolution of vancomycin resistance D,D-peptidases.

Authors:  Djalal Meziane-Cherif; Peter J Stogios; Elena Evdokimova; Alexei Savchenko; Patrice Courvalin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

Review 3.  Molecular mechanisms of vancomycin resistance.

Authors:  Peter J Stogios; Alexei Savchenko
Journal:  Protein Sci       Date:  2020-01-23       Impact factor: 6.725

4.  An Acinetobacter baumannii, Zinc-Regulated Peptidase Maintains Cell Wall Integrity during Immune-Mediated Nutrient Sequestration.

Authors:  Zachery R Lonergan; Brittany L Nairn; Jiefei Wang; Yen-Pang Hsu; Laura E Hesse; William N Beavers; Walter J Chazin; Jonathan C Trinidad; Michael S VanNieuwenhze; David P Giedroc; Eric P Skaar
Journal:  Cell Rep       Date:  2019-02-19       Impact factor: 9.423

5.  Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO.

Authors:  Jeffrey G Marblestone; Suzanne C Edavettal; Yiting Lim; Peter Lim; Xun Zuo; Tauseef R Butt
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

6.  Streptomyces spp. as efficient expression system for a D,D-peptidase/D,D-carboxypeptidase involved in glycopeptide antibiotic resistance.

Authors:  Elisa Binda; Giorgia Letizia Marcone; Francesca Berini; Loredano Pollegioni; Flavia Marinelli
Journal:  BMC Biotechnol       Date:  2013-03-16       Impact factor: 2.563

7.  Genomic Insights into the Distribution and Phylogeny of Glycopeptide Resistance Determinants within the Actinobacteria Phylum.

Authors:  Andrés Andreo-Vidal; Elisa Binda; Victor Fedorenko; Flavia Marinelli; Oleksandr Yushchuk
Journal:  Antibiotics (Basel)       Date:  2021-12-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.